Skip to main content
SpringerLink
Log in

Adalimumab/mercaptopurine/mesalazine

Epstein-Barr virus and cytomegalovirus infections: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kato M, et al. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab. Journal of Infection and Chemotherapy 28: 823-827, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1016/j.jiac.2022.01.018

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/mercaptopurine/mesalazine. Reactions Weekly 1909, 23 (2022). https://doi.org/10.1007/s40278-022-16310-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16310-1

Search

Navigation